Home › Kanser sa Ovary › Arizona › Phoenix

Pag-aaral pangklinika para sa Kanser sa Ovary sa Phoenix, AZ

Isang pag-aaral para sa Kanser sa Ovary ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Phoenix. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Nagre-recruitObservasyonal na pag-aaral

Mayo Clinic, Phoenix

Edad 18 pataas · Kababaihan · Na-update Set 29, 2026 · NCT05051722

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Nagre-recruitPhase 2

Site 0143 - HonorHealth, Phoenix

Edad 18 pataas · Kababaihan · Na-update Set 29, 2026 · NCT05128825

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Nagre-recruitObservasyonal na pag-aaral

Mayo Clinic Hospital, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04981119

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Nagre-recruitPhase 3

HonorHealth, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213804

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

Nagre-recruitPhase 3

Site 0107, Phoenix

Edad 18 pataas · Kababaihan · Na-update Ago 12, 2026 · NCT07546500

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Nagre-recruitPhase 3

Cancer Center at Saint Joseph's, Phoenix
Mayo Clinic Hospital in Arizona, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06580314

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Nagre-recruitPhase 1/2

USOR HonorHealth, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

Nagre-recruitPhase 3

Mayo Clinic Arizona, Phoenix

Edad 18 pataas · Kababaihan · Na-update Hul 14, 2026 · NCT05804370

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Nagre-recruitPhase 1/2

Mayo Clinic Comprehensive Cancer Center, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT05377996

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Nagre-recruitPhase 1/2

Mayo Clinic, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06395519

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Nagre-recruitPhase 2

Mayo Clinic Hospital, Phoenix

Edad 18 pataas · Kababaihan · Na-update Dis 23, 2025 · NCT06690775

Pag-aaral para sa Kanser sa Ovary sa ibang lungsod

Iba pang pag-aaral sa Phoenix

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.